KWM
INSM icon

Kingsview Wealth Management’s Insmed INSM Stock Holding History

Kingsview Wealth Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$342K Buy
2,089
+18
+0.9% +$2.77K ﹤0.01% 1025
2025
Q4 		$360K Sell
2,071
-250
-11% -$45.6K 0.01% 964
2025
Q3 		$334K Buy
2,321
+60
+3% +$7.35K 0.01% 927
2025
Q2 		$228K Buy
+2,261
New +$173K ﹤0.01% 1060

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Kingsview Wealth Management's INSM Position: Q1 2026 in Review

Kingsview Wealth Management increased its Insmed (INSM) stake by 0.87% in Q1 2026, buying an estimated $2.77K and bringing the position to 2,089 shares worth $342K. The position accounts for ﹤0.01% of the portfolio, ranked #1025.

Kingsview Wealth Management first reported a position in INSM in Q2 2025 and has held it in 4 quarters since. The position peaked at $360K in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Kingsview Wealth Management held 2,089 shares of Insmed worth $342K as of Q1 2026.
  • Kingsview Wealth Management bought 18 Insmed shares in Q1 2026, an estimated $2.77K.
  • Insmed made up ﹤0.01% of Kingsview Wealth Management's portfolio in Q1 2026, its #1025 holding.
  • Kingsview Wealth Management first reported a position in Insmed in Q2 2025 and has held it in 4 quarters since.
  • Kingsview Wealth Management's Insmed position peaked at $360K in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.